Ask AI

Genitourinary Cancers

Share

Program Content

Activities

  • ARCHES 5 Year OS
    ARCHES: Post Hoc Analysis of 5-Yr OS Outcomes for Phase III Trial of Enzalutamide + ADT vs Placebo + ADT in Patients With mHSPC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 01, 2025

    Expires: November 30, 2025

Supporters

Supported by an educational grant from Astellas.

Astellas